CYRX News 0.4500 Cryoport Inc (CYRX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cryoport Inc (CYRX) 0.4500 $CYRX

Merriman Capital Markets Group Hosting Healthcare Spotlight Investor Event
Thomson Reuters ONE - Thu Apr 03, 3:05PM CDT
SAN FRANCISCO - April 3, 2014 - Merriman Capital, Inc. ("Merriman", a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce that it will be hosting an investor event highlighting three of its healthcare-focused Capital Markets Advisory Clients.

Cryoport and European Mouse Mutant Archive Enter into Global Agreement to Provide Full-Service Logistics Solutions for Frozen Biomaterials
PR Newswire Europe - Tue Apr 01, 7:01AM CDT
- Critical frozen logistics solution supports shipments of mouse mutant lines to EMMA clients in more than 40 different countries with a focus on Europe and Northern America

Cryoport, Inc. Retains KCSA Strategic Communications as U.S. Investor Relations Counsel
PR Newswire - Thu Mar 27, 8:18AM CDT
Cryoport, Inc. (OTC BB: CYRX), the only end-to-end cryogenic logistics solutions provider, today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations program.

10-Q: CRYOPORT, INC.
Edgar Online - Thu Feb 13, 12:05PM CST
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Cryoport Increases Revenues By 149% For The First Nine Months of Fiscal 2014
Business Wire - Thu Feb 13, 5:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and nine months ended December 31, 2013.

Liventa Bioscience and Cryoport Form Alliance to Deliver Cell-Based Biologics to Point-of-Service Orthopedic Care
Business Wire - Wed Feb 05, 5:20PM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell-based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.

Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point-of-Service Orthopedic Care
PR Newswire - Wed Feb 05, 8:30AM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.

Cryoport Revenues Increased 151% for the First Half of Fiscal 2014
Business Wire - Mon Nov 18, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and six months ended September 30, 2013.

Cryoport to Present at LD Micro Growth Conference on December 3, 2013
Business Wire - Fri Nov 15, 3:08PM CST
Cryoport, Inc. (OTCBB: CYRX) today announced that Chief Executive Officer Jerrell Shelton and Chief Financial Officer Robert Stefanovich are scheduled to present to investors at the 6th Annual LD Micro Growth Conference on Tuesday, December 3, 2013 at 3:00 PM PST.

Cryoport Elects Edward Zecchini to Board of Directors
Business Wire - Mon Sep 16, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced it has elected Edward J. Zecchini to its Board of Directors. Mr. Zecchini is an established technology leader with over thirty years of experience in the healthcare and information technology industries. With this appointment, the Cryoport Board now has four members, of which three are independent directors, including Mr. Zecchini.

Cryoport Inc signs turnkey logistics solutions agreement with The World Egg Bank for shipment of human eggs
M2 - Tue Aug 20, 7:17AM CDT
Frozen shipping logistics company Cryoport Inc (OTC BB:CYRX) reported on Monday the expansion of its logistics services for reproductive medicine using its advanced turnkey logistics solution technology.

Cryoport Expands Logistics Services for Reproductive Medicine with The World Egg Bank
Business Wire - Mon Aug 19, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) continues its momentum as leader in advanced logistics services for reproductive medicine with The World Egg Bank (TWEB) using its advanced technology "turnkey logistics solution." Through its partnership, TWEB employs Cryoport's cloud-based logistics management software platform (known as the Cryoportal(TM)) complemented by its patented dry vapor Cryoport Express(R) Shippers and Cryoport's logistics expertise. TWEB successfully ships their critical customer products in this manner, both domestically and internationally.

Cryoport Generates Strong Interest for Its Cryogenic Logistics Solution for Reproductive Medicine
Business Wire - Thu Aug 15, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) recently showcased its Cryoport Express(R) logistics solutions during the 29th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in London. This critical meeting was the kickoff for Cryoport's expanded presence within the EU reproductive medicine arena.

Cryoport and Zoetis Expand Cold Chain Logistics Relationship
Business Wire - Mon Jul 22, 11:06AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced that it has reached agreement with Zoetis Inc. (formerly the animal health business unit of Pfizer Inc.) to expand the scope of the cold chain logistics services Cryoport is providing.

Cryoport Inc doubles revenues to USD1.1m in fiscal 2013, with sales growth continueing to increase in fiscal 2014
M2 - Fri Jun 07, 4:59AM CDT
Frozen shipping logistics company Cryoport Inc (OTC BB:CYRX) reported on Thursday a net loss of USD6.4m for the fiscal year ended 31 March 2013.

Cryoport Doubles Revenues for Fiscal 2013
Business Wire - Thu Jun 06, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced preliminary financial results for the fiscal fourth quarter and year ended March 31, 2013. Revenues for fiscal 2013 were $1.1 million, an increase of 98%, compared with revenues of $556,000 in fiscal 2012. Operating expenses in fiscal 2013 were $5.8 million, down 12%, compared with operating expenses of $6.6 million in fiscal 2012. Excluding stock-based expenses, operating expenses in fiscal 2013 were $5.1 million, down 15%, compared with $6.0 million in fiscal 2012. The net loss in fiscal 2013 was $6.4 million, compared with a net loss of $7.8 million in fiscal 2012.

Cryoport Appoints Richard Rathmann to Board of Directors
Business Wire - Mon Apr 01, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced it has appointed Richard G. Rathmann to its Board of Directors. Mr. Rathmann is an experienced venture fund manager and advisor to life science companies. With this appointment, the Cryoport Board now has five members, of which four are considered independent directors, including Mr. Rathmann.

Cryoport to Provide Full Range of Deep Frozen Shipping and Logistics Services to Clinical Reference Laboratory
Business Wire - Mon Jan 14, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced that it is expanding its services to Clinical Reference Laboratory (CRL) for the transportation of high-value test samples and specimens. CRL is a leading provider of testing services for clinical trials, molecular diagnostics and toxicology.

Cryoport Inc adds Bill Taaffe to CAB
M2 - Tue Jan 08, 7:13AM CST
Frozen shipping logistics company Cryoport Inc (OTC BB :CYRX) stated on Monday that Bill Taaffe has been selected as a member of its newly formed Commercial Advisory Board (CAB).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 8

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 5

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 39

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 43

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading

Top 5 Most Recently Viewed Articles

Colossus SSP Partners with Scope3 for Sustainable Advertising

Updated Category News Views 852

Colossus SSP Teams Up with Scope3 for Green Media Solutions Colossus Media LLC, also known as Colossus SSP, is making strides in the advertising sector by integrating with Scope3, a prominent provider of carbon emissions data. This collaboration empowers Colossus SSP to present superior green media solutions, thereby allowing brands and agencies to show greater commitment...

Continue Reading
SSC Security Services Enhances Structure Through Amalgamation

Updated Category News Views 110

SSC Security Services Corp. Completes Subsidiary Amalgamation SSC Security Services Corp., commonly referred to as SSC, is pleased to announce the successful completion of a horizontal short-form amalgamation of its wholly owned operating subsidiaries, Logixx Security Inc. and SRG Security Resource Group Inc. This strategic move is part of a larger effort to streamline...

Continue Reading
Biden Administration Takes Action to Enhance Airline Competition

Updated Category News Views 64

Biden Administration Takes a Firm Stand on Airline Competition The U.S. government is stepping up efforts to ensure fair competition in the airline industry. The Justice Department's Antitrust Division, along with the Transportation Department, has initiated a comprehensive public inquiry into the landscape of air travel competition. Prioritizing Airline Competition...

Continue Reading
Atlassian Reports Exceptional Growth in Fiscal Performance

Updated Category News Views 101

Atlassian's Strong Fiscal Performance Atlassian Corp Plc (NASDAQ: TEAM) has recently delivered its fiscal first quarter results, much to the delight of analysts and investors alike. The report highlighted impressive growth in both its cloud and data center sectors, which significantly contributed to its revenues, surpassing Wall Street's expectations. Highlights from the...

Continue Reading
Actinium Pharmaceuticals Lawsuit: What Investors Should Know Now

Updated Category News Views 238

Actinium Pharmaceuticals Class Action Lawsuit Overview In recent developments surrounding Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), investors are presented with an opportunity to lead a securities fraud class action lawsuit. This initiative is spearheaded by Rosen Law Firm, a reputable global entity vigorously advocating for investor rights. Key Details for...

Continue Reading